Skip to content

Infinity Pharmaceuticals, Inc.: filings

Every Infinity Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 49 filings, each linked to its SEC index.

Filing record ends 2023-08-10

The latest filing in this captured record is a 10-Q filed 2023-08-10. No later filing is in the SEC companyfacts record captured on 2026-09-22. Infinity Pharmaceuticals, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-08-10fiscal Q2 202333990001113148-23-000009
10-Q2023-05-09fiscal Q1 202332690001113148-23-000006
10-K2023-03-28fiscal FY 202240820001113148-23-000003
10-Q2022-11-14fiscal Q3 2022341010001113148-22-000022
10-Q2022-08-09fiscal Q2 2022351030001113148-22-000018
10-Q2022-05-03fiscal Q1 202235750001113148-22-000012
10-K2022-03-29fiscal FY 202142860001113148-22-000007
10-Q2021-11-02fiscal Q3 2021351030001113148-21-000023
10-Q2021-07-27fiscal Q2 2021351030001113148-21-000019
10-Q2021-05-13fiscal Q1 202131670001113148-21-000013
10-K2021-03-16fiscal FY 202038780001113148-21-000007
10-Q2020-11-09fiscal Q3 202032910001113148-20-000039
10-Q2020-07-30fiscal Q2 202031890001113148-20-000028
10-Q2020-05-11fiscal Q1 202031670001113148-20-000016
10-K2020-03-03fiscal FY 201938750001113148-20-000004
10-Q2019-10-30fiscal Q3 2019401160001113148-19-000013
10-Q2019-07-30fiscal Q2 201936980001113148-19-000008
10-Q2019-05-07fiscal Q1 201935720001113148-19-000005
10-K2019-03-14fiscal FY 201837770001113148-19-000002
10-Q2018-11-05fiscal Q3 2018371060001113148-18-000013
10-Q2018-08-07fiscal Q2 201830820001113148-18-000010
10-Q2018-05-08fiscal Q1 201830640001113148-18-000007
10-K2018-03-15fiscal FY 2017351630001113148-18-000004
10-Q2017-11-07fiscal Q3 201728760001113148-17-000013
10-Q2017-08-03fiscal Q2 201731920001113148-17-000010
10-Q2017-05-09fiscal Q1 201726540001113148-17-000006
10-K2017-03-14fiscal FY 2016361860001113148-17-000003
10-Q2016-11-09fiscal Q3 201633980001113148-16-000011
10-Q2016-08-09fiscal Q2 201632940001113148-16-000009
10-Q2016-05-04fiscal Q1 201627560001113148-16-000007
10-K2016-02-23fiscal FY 2015361780001193125-16-473445
10-Q2015-11-05fiscal Q3 201534970001193125-15-368134
10-Q2015-08-06fiscal Q2 201528750001193125-15-279968
10-Q2015-05-06fiscal Q1 201527560001193125-15-173304
10-K2015-02-24fiscal FY 2014361560001193125-15-060050
10-Q2014-11-10fiscal Q3 201431880001193125-14-405976
10-Q2014-08-11fiscal Q2 201426680001193125-14-303968
10-Q2014-05-06fiscal Q1 201426530001193125-14-184776
10-K2014-02-25fiscal FY 2013361470001193125-14-066107
10-Q2013-11-07fiscal Q3 201334910001193125-13-432729
10-Q2013-08-08fiscal Q2 201329740001193125-13-325531
10-Q2013-05-07fiscal Q1 201329590001193125-13-204326
10-K2013-03-05fiscal FY 2012371530001193125-13-091650
10-Q2012-11-06fiscal Q3 201234930001193125-12-453167
10-Q2012-08-07fiscal Q2 201230780001193125-12-339352
10-Q2012-05-08fiscal Q1 201230620001193125-12-218293
10-K2012-03-13fiscal FY 201132820001193125-12-111977
10-Q2011-11-08fiscal Q3 201130760001193125-11-302185
10-Q2011-08-09fiscal Q2 201129740001193125-11-216464

Inspect the source

Entity
Infinity Pharmaceuticals, Inc. / CIK 0001113148
Captured
SEC response SHA-256
0858ec810f703190d9cf4fc70940e32b221bca20fa5f9dd194f161e324958f08

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001113148.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))